- Home
- GROY vs LFCR Comparison
GROY vs LFCR Comparison
Compare GROY & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROY
- LFCR
- Stock Information
- Founded
- GROY 2020
- LFCR 1986
- Country
- GROY Canada
- LFCR United States
- Employees
- GROY 16
- LFCR N/A
- Industry
- GROY
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- GROY
- LFCR Health Care
- Exchange
- GROY Nasdaq
- LFCR Nasdaq
- Market Cap
- GROY 618.0M
- LFCR 308.8M
- IPO Year
- GROY 2021
- LFCR N/A
- Fundamental
- Price
- GROY $3.62
- LFCR $7.61
- Analyst Decision
- GROY Strong Buy
- LFCR Buy
- Analyst Count
- GROY 4
- LFCR 4
- Target Price
- GROY $4.58
- LFCR $8.00
- AVG Volume (30 Days)
- GROY 2.5M
- LFCR 108.3K
- Earning Date
- GROY 08-06-2025
- LFCR 08-07-2025
- Dividend Yield
- GROY N/A
- LFCR N/A
- EPS Growth
- GROY N/A
- LFCR N/A
- EPS
- GROY N/A
- LFCR N/A
- Revenue
- GROY $12,376,000.00
- LFCR $128,867,000.00
- Revenue This Year
- GROY $82.74
- LFCR $4.78
- Revenue Next Year
- GROY $51.73
- LFCR $12.02
- P/E Ratio
- GROY N/A
- LFCR N/A
- Revenue Growth
- GROY 90.37
- LFCR 0.47
- 52 Week Low
- GROY $1.16
- LFCR $3.68
- 52 Week High
- GROY $3.65
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- GROY 65.91
- LFCR 53.94
- Support Level
- GROY $2.89
- LFCR $7.33
- Resistance Level
- GROY $3.37
- LFCR $7.73
- Average True Range (ATR)
- GROY 0.15
- LFCR 0.30
- MACD
- GROY 0.01
- LFCR 0.03
- Stochastic Oscillator
- GROY 85.59
- LFCR 65.33
About GROY Gold Royalty Corp.
Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.